Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

Das, J. orcid.org/0000-0002-9166-4624, Snowden, J.A. orcid.org/0000-0001-6819-3476, Burman, J. et al. (10 more authors) (2021) Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis. Multiple Sclerosis Journal. ISSN 1352-4585

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s), 2021. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: Autologous haematopoietic stem cell transplantation; multiple sclerosis; aggressive multiple sclerosis; disease-modifying therapy; no evidence of disease activity
Dates:
  • Accepted: 11 December 2020
  • Published (online): 10 February 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 12 Mar 2021 15:58
Last Modified: 12 Mar 2021 15:58
Status: Published online
Publisher: SAGE Publications
Refereed: Yes
Identification Number: https://doi.org/10.1177/1352458520985238
Related URLs:

Download

Share / Export

Statistics